Navigation Links
Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt
Date:5/22/2013

PHILADELPHIA, 22. Mai 2013 /PRNewswire/ -- Grifols, ein globales Unternehmen der Gesundheitsbranche mit Sitz in Barcelona, Spanien, präsentierte die Ergebnisse einer Studie, die aufzeigt, dass eine höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des Alpha1-Proteins in Patienten mit Alpha1-Antitrypsinmangel (AAT) auf ein Niveau anhebt, das innerhalb des für gesunde Menschen normal bezeichneten Bereichs liegt. ATT-Mangel ist eine lebensbedrohliche, genetische Erkrankung, bei der der niedrige Spiegel des Alpha1-Proteinasehemmer-Proteins (A1PI) zu Emphysemen führen kann.

Die Ergebnisse der PROLASTIN-C SPARK-Studie, eine pharmakokinetische klinische Studie mit Mehrfachdosen, wurden am 21. Mai auf der Jahrestagung der American Thoracic Society (ATS) präsentiert. Die Daten der Studie zeigten, dass wöchentliche Infusionen von PROLASTIN-C bei 120 mg/kg die Serumkonzentration des A1PI-Proteins auf ein proportional höheres Niveau brachte als wöchentliche Infusionen von 60 mg/kg, die derzeit für PROLASTIN-C zugelassene Dosis. Des Weiteren erhöhte die Dosis von 120 mg/kg die Serumkonzentration von A1PI in den mikromolaren Bereich von 20 - 53, der bei gesunden Menschen als normal angesehen wird. Beide Dosen waren sicher und wurden von den Probanden mit AAT-Mangel gut toleriert.

„Diese Daten zeigen, dass die Dosis von 120 mg/kg PROLASTIN-C zu höheren physiologischen A1PI-Konzentrationen führt als die derzeit empfohlene Dosis von 60 mg/kg, und sie bestätigen das vorhersehbare PK-Profil der Augmentationstherapie", unterstreicht Dr. Mark Brantly , Professor für Medizin am University of Florida College of Medicine.

Grifols verwendet die Daten der SPARK-Studie als Basis für eine größ
'/>"/>

SOURCE Grifols
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. RNL BIO Co. Ltd. stellt IND-Antrag, um klinische Phase-II-Studie des RNL-JointStem gegen Arthrose in den Vereinigten Staaten einzuleiten
2. Acutus Medical, Inc. erprobt erstmals seinen Echtzeit-3D-Bildgebungskatheter von CT/MRI-Qualität in einer klinischen Studie am Menschen
3. Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
4. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
5. Eine in European Radiology veröffentlichte Studie untermauert den Nutzen von Hologics Brust-Tomosynthese beim Screening bei Verfahren mit Zweitbefundung
6. Neuartige Krebsimmuntherapie für den Beginn klinischer Studien bereit
7. Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
8. Studies Published in Pain Medicine Demonstrate Effectiveness of Minimally-Invasive Cooled Radiofrequency Treatment for Low Back Pain
9. Grant Awarded to Study Novel Therapies for Muco-Obstructive Diseases Includes Studies on Cempras Solithromycin (CEM-101) in a Cystic Fibrosis Anti-inflammatory Model
10. Managing Bioequivalence Studies to Optimize Cost, Quality, and Outsourcing of Generics Manufacturing
11. Studies Show Pharma has a Strong Opportunity to Market to New Decision Makers via Digital Channels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... N.C. , April 24, 2015  New ... ability of consumers to educate themselves about products ... the tools and techniques available to market researchers ... the changing consumer marketplace, it,s imperative that organizations ... to better identify market opportunities, niches and growth ...
(Date:4/24/2015)... 24, 2015   Vestagen Technical Textiles, Inc. ... , has recently received two notable innovation awards. The ... that recognizes innovations with potential to create a positive ... in New York City , VESTEX ... "Protection & Safety" category. The awards honor excellence in ...
(Date:4/24/2015)... Boston Scientific Corporation (NYSE: BSX ) is ... Annual Healthcare Conference on May 6 in Boston ... president and chief financial officer, and Susie Lisa , ... and answer session regarding the company with the host analyst ... of the presentation and question and answer session will be ...
Breaking Medicine Technology:Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2
... -- La Jolla,Pharmaceutical Company today announced updated interim ... Riquent(R) (abetimus,sodium), its drug candidate for systemic lupus ... previous,conclusion that there is a definitive and significant ... 900 mg doses of Riquent compared,with placebo (p=0.0001). ...
... N.J., March 20, 2007 /PRNewswire-FirstCall/ --,Alfacell Corporation's ... a potent payload in antibody conjugates for ... the Handbook of Therapeutic,Antibodies. , In a ... Susanna,Rybak, Ph.D. summarizes preclinical research indicating that ...
Cached Medicine Technology:La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 2Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 3Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 4
(Date:4/25/2015)... ME (PRWEB) April 26, 2015 ... Canadian based integrative healthcare event. The Integrative Healthcare ... place October 23-24, 2015 at the Sheraton Parkway ... Symposium Canada is one of the most anticipated ... clinically relevant, evidenced-based CME program. The event aims ...
(Date:4/25/2015)... April 25, 2015 The federal ... mesh lawsuits filed against C.R. Bard, Inc. continues ... Southern District of West Virginia. According to a ... was convened that day, after certain defendants submitted ... Complaint. The Order directed that any Preliminary Motions ...
(Date:4/25/2015)... Illinois (PRWEB) April 25, 2015 ... enrichment and wellness, management and operations, and sales ... Meeting and Exhibition scheduled to be held from ... , LeadingAge Illinois is the largest eldercare association ... providers of services for older adults, including senior ...
(Date:4/25/2015)... April 25, 2015 For thirteen years, the ... income protection education event in the nation! This year, on ... Plus Group, US to take DI Day on the road ... G. Davidson, CLU, ChFC, RHU, DIA, CLTC, Chief Executive Officer ... Day reflects on the change by stating, "The first Twin ...
(Date:4/24/2015)... Foothill Ranch, California (PRWEB) April 24, 2015 ... that has a wide range of capabilities and services ... etc. , Ryadon's Quantity Discount Program will be ... ) as follows: , Order 4-19: Receive 10% discount ... Can Benefit by Using the Drawer Slides Products, ...
Breaking Medicine News(10 mins):Health News:Integrative Healthcare Event launching in Canada 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:Secura Consultants Takes DI Day On The Road 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3
... from the University of Hull has told the British Psychological ... eating chocolate, lazing in front of the television, or going ... could make them more susceptible to disease.Those on the other ... to fight off infection.// ,Researchers asked 30 students ...
... a new gel, which works in a similar way to ... stomach each day, is being tested in four countries world-wide.For ... popping the contraceptive pill. But now there's a new option ... Association says "The gel is like any other gel, but ...
... in the devastated NewYork of America nor in the Afghanistan! It ... And who are the warring parties? They are the pharmaceutical industry ... Chemists Association. The latter is a member body of over 5,000 ... R Shah. // ,It is a classic case of ...
... Researchers in the US have found that genes contribute ... smoking. Chronic obstructive pulmonary disease (COPD), the name given ... because it leads to increasing shortness of breath. It's ... is a major cause of the problem.// ...
... the brain helps people recognise themselves in a picture, ... Deaconess Medical Center in Boston report their findings in ... a growing body of evidence that demonstrates the right ... self-awareness may provide unique insights into consciousness and doctors ...
... People who drink and smoke have to drink more ... greater risk of damage to their brains, livers and hearts, ... reduces blood alcohol levels in rats, which are considered a ... they will end up drinking more alcohol to get an ...
Cached Medicine News:Health News:The right is responsible 2
Straight shafts 4 mm platform. Wide serrated handle with dull finish. Platform angled 45 degrees....
Curved shafts with 3.5 mm angled platform and dull finish. Wide serrated handle with dull finish....
Double-ended. 10 mm sickle shaped blade. 27 mm blunt, curved double-edged blade....
Fixed smooth rod which slides on skin. Designated most popular model or size....
Medicine Products: